Authors: Kinzie, JL Naylor, PH Nathani, MG Peleman, RR Ehrinpreis, MN Lybik, M Turner, JR Janisse, JJ Massanari, M Mutchnick, MG

Citation: Jl. Kinzie et al., African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians, J VIRAL HEP, 8(4), 2001, pp. 264-269

Authors: Kirkley, JE Goldstein, AL Naylor, PH

Citation: Je. Kirkley et al., Effect af peptide-carrier coupling an peptide-specific immune responses, IMMUNOBIOL, 203(4), 2001, pp. 601-615

Authors: Bianco-Batlles, D Naylor, CW Moshier, JA Dosescu, J Naylor, PH

Citation: D. Bianco-batlles et al., Clonal growth inhibition as a bioassay for thymosin alpha 1: Inactivation of T alpha 1 by trifluroacetic acid, CELL MOL B, 47(1), 2001, pp. 157-160

Authors: Geng, H Naylor, PH Dosescu, J Skunca, M Majumdar, APN Moshier, JA

Citation: H. Geng et al., TGF alpha is required for full expression of the transformed growth phenotype of NIH 3T3 cells overexpressing ornithine decarboxylase, CARCINOGENE, 21(4), 2000, pp. 567-572

Authors: Naylor, PH Naylor, CW Hendrix, S Leveque, FG

Citation: Ph. Naylor et al., Oral administration of interferon-alpha induces a transient decline in oral mucosal immunoglobulins and an increase in interleukin-5, J INTERF CY, 19(8), 1999, pp. 953-959